Skip to main content

Ascorbic Acid in Charcot-Marie-Tooth Disease Cover

Ascorbic Acid in Charcot-Marie-Tooth Disease

Pediatric Neurology Briefs

Volume 23 (2009): Issue 12

By: J Gordon Millichap

Open Access

|Dec 2009

Abstract

Ascorbic acid has been shown to reduce demyelination and improve muscle function in a transgenic mouse model of Charcot-Marie-Tooth disease (CMT1A).

References

Micallef J Attarian S Dubourg O Gonnaud PM Hogrel JY Stojkovic T Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomized, double-blind, placebo-controlled trial Lancet Neurol 2009 Dec 8 12 1103 1110 10.1016/S1474-4422(09)70260-1 19818690
Open DOI Search in Google Scholar Back to article
Burns J Ouvrier RA Yiu EM Joseph PD Kornberg AJ Fahey MC Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial Lancet Neurol 2009 Jun 8 6 537 44 10.1016/S1474-4422(09)70108-5 19427269
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-23-12-11 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 96 - 96

Published on: Dec 1, 2009

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Charcot-Marie-Tooth Disease,

cAMP-Mediated Stimulation,

© 2009 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 23 (2009): Issue 12

Previous article